Batelapine

Batelapine

Clinical data
Other names	CGS-13429
Routes of administration	By mouth
ATC code	None
Pharmacokinetic data
Elimination half-life	8.1 Hours
Identifiers
IUPAC name 2-methyl-5-(4-methylpiperazin-1-yl)-11H-[1,2,4]triazolo[1,5-c][1,3]benzodiazepine
CAS Number	95634-82-5^Y
PubChem CID	60717
ChemSpider	6721^N
UNII	P71TE299SG
ChEMBL	ChEMBL2110765^N
CompTox Dashboard (EPA)	DTXSID50241906
Chemical and physical data
Formula	C16H20N6
Molar mass	296.378 g·mol^−1
3D model (JSmol)	Interactive image
SMILES CC1=NN2C(=N1)CC3=CC=CC=C3N=C2N4CCN(CC4)C
InChI InChI=1S/C16H20N6/c1-12-17-15-11-13-5-3-4-6-14(13)18-16(22(15)19-12)21-9-7-20(2)8-10-21/h3-6H,7-11H2,1-2H3^Y Key:PUHMYHQVPODHCZ-UHFFFAOYSA-N^Y

Batelapine (developmental code name CGS-13429) is a structural analogue of clozapine which was investigated as a potential antipsychotic.^[1][2]

References

1. Chovan JP, Vermeulen JD (September 1989). "High-performance liquid chromatographic method for a clozapine analogue, CGS 13429, and its N-oxide and desmethyl metabolites". Journal of Chromatography. 494: 413–9. doi:10.1016/s0378-4347(00)82697-3. PMID 2573611.
2. "Batelapine - AdisInsight".

External links

• Batelapine - AdisInsight